Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Heart Journal

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MHJ.2002.125513PMID 12177638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.

  2001cited by this paper
• Management of patients with chronic renal insufficiency in the Northeastern United States.

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.

  2001cited by this paper
• Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project.

  2000cited by this paper
• Long-term survival of renal transplant recipients in the United States after acute myocardial infarction.

  2000cited by this paper
• Risks associated with renal dysfunction in patients in the coronary care unit.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Effect of Beta-Blockade on Mortality Among High-Risk and Low-Risk Patients After Myocardial Infarction

  1999cited by this paper
• β Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study

  1999cited by this paper
• Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

  1998cited by this paper
• Renal Dysfunction after Myocardial Revascularization: Risk Factors, Adverse Outcomes, and Hospital Resource Utilization

  1998cited by this paper
• Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

  1998cited by this paper
• The Henry Ford Health System

  1998cited by this paper
• Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

  1997cited by this paper
• Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke.

  1997cited by this paper
• Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population.

  1997cited by this paper
• Preoperative renal risk stratification.

  1997cited by this paper
• Henry Ford Health System medical information management system: strategy for creating a community-wide health information system.

  1995cited by this paper
• Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality

  1994cited by this paper
• Predictability of creatinine clearance estimates in critically ill patients

  1993cited by this paper
• Cardiovascular disease risk profiles.

  1991cited by this paper
• Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.

  1987cited by this paper
• Bleeding time in Uremia: A useful test to assess clinical bleeding

  1979cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety

  2025influential citation
• Acute Myocardial Infarction and Chronic Kidney Disease

  2024cites this paper
• Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate

  2024cites this paper
• Comparison of the effectiveness and safety of two aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: a subgroup analysis of ADAPTABLE.

  2023cites this paper
• Incidence, risk factors and outcomes of acute kidney injury in surgical intensive care unit octogenarians at the Jordan University Hospital

  2023cites this paper
• Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease.

  2023cites this paper
• Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications

  2022cites this paper
• Chronic Kidney Disease and Myocardial Infarction

  2022cites this paper
• Beta-blocker therapy in elderly patients with renal dysfunction and heart failure

  2021influential citation
• Dose, dosage regimen, and dose adjustment in organ failure

  2021cites this paper
• Cardiovascular Events After Partner Bereavement, What is the Role of Low Dose Aspirin and Beta-Blockers?

  2021cites this paper
• Framing Cause-Effect Relationship of Acute Coronary Syndrome in Patients with Chronic Kidney Disease

  2021cites this paper
• Low eGFR and albuminuria independently predict all-cause mortality in high-risk subjects undergoing coronary arteriography

  2021cites this paper
• Pain and Chronic Kidney Disease

  2020cites this paper
• KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.

  2020cites this paper
• Antiplatelet Agent Choice and Platelet Function Testing in CKD

  2020cites this paper
• Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China.

  2020cites this paper
• Blockade of Renin–Angiotensin–Aldosterone System in Elderly Patients with Heart Failure and Chronic Kidney Disease: Results of a Single-Center, Observational Cohort Study

  2019cites this paper
• Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience.

  2019cites this paper
• Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction.

  2019cites this paper
• Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence

  2019cites this paper
• Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study

  2018cites this paper
• Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain–MI Registry

  2018cites this paper
• Beta blockers in patients with end‐stage renal disease—Evidence‐based recommendations

  2018cites this paper
• Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function

  2017cites this paper
• Antithrombotic therapy in end‐stage renal disease

  2017cites this paper
• Antiplatelet agents in hemodialysis

  2017cites this paper
• Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review

  2017cites this paper
• Recent Trends in Management and Inhospital Outcomes of Acute Myocardial Infarction in Renal Transplant Recipients.

  2017cites this paper
• P Renal Insufficiency and Heart Failure he Association Among Renal nsufficiency , Pharmacotherapy , nd Outcomes in 6 , 427 Patients With eart Failure and Coronary Artery Disease

  2016cites this paper
• Diab-10-0431 Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and mortality in type 2 diabetes mellitus : the FIELD study

  2016cites this paper
• Influence of Renal Insufficiency on the Prescription of Evidence-Based Medicines in Patients With Coronary Artery Disease and Its Prognostic Significance

  2016cites this paper
• Beta-Blocker Use Is Associated with Higher Renal Tissue Oxygenation in Hypertensive Patients Suspected of Renal Artery Stenosis

  2016cites this paper
• Renal insufficiency and mortality in coronary artery disease with reduced ejection fraction.

  2016cites this paper
• Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study

  2016cites this paper
• Can routinely collected primary care data determine the prevalence of chronic kidney disease and predict clinical events in patients with stages 3 of the disease

  2015cites this paper
• Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).

  2015cites this paper
• Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.

  2015cites this paper
• Strategies of Hyperglycemia Management among Patients with Diabetic Nephropathy, Renal Impairment, Hypertension and Lipid Disorders

  2015cites this paper
• ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome

  2014cites this paper
• American College of Cardiology Foundation Candidates: A Scientific Statement From the American Heart Association and the Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation

  2014cites this paper
• Clinical Features, Use of Evidence‐Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non–ST‐Elevation Acute Coronary Syndrome

  2014cites this paper
• Antihypertensive Medication Exposure and Cardiovascular Outcomes in Hemodialysis Patients

  2014cites this paper
• [Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease].

  2014cites this paper
• Peter Andrew McCullough, MD, MPH: an interview with the editor.

  2014cites this paper
• Kronik böbrek yetersizliği bulunan hastalarda antitrombosit ilaçlarin etkinliği ve emniyeti Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease

  2014cites this paper
• Chronische nierschade

  2014cites this paper
• Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease

  2014cites this paper
• The risk of atherosclerosis in patients with chronic kidney disease

  2013cites this paper
• Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study.

  2013cites this paper
• High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention From the American Heart Association Councils on Kidney in Cardiovascular Disease, Kidney Disease as a Risk Factor for Development of Cardiovascular Disease : A Statement

  2013cites this paper
• Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease

  2013cites this paper
• Effects of exercise and lifestyle intervention on cardiovascular function in CKD.

  2013cites this paper
• Documento ANMCO/SICI-GISE sulla terapia antiaggregante nelle sindromi coronariche acute

  2013cites this paper
• Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome.

  2013cites this paper
• Antiplatelet agents for chronic kidney disease.

  2013cites this paper
• Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era.

  2013cites this paper
• Predictors of Beta-Blocker Intolerance and Mortality in Patients After Acute Coronary Syndrome

  2013cites this paper
• Coronary artery disease in dialysis patients: What is the optimal therapy?

  2013influential citation
• Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

  2012cites this paper
• Chronic kidney disease as a risk factor for acute coronary syndromes in patients presenting to the emergency room with chest pain.

  2012cites this paper
• Interface Between Renal Disease and Cardiovascular Illness

  2012cites this paper
• AHA / ACCF Scientific Statement Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

  2012cites this paper
• Treatment of the Patient with End‐Stage Diabetic Nephropathy

  2012cites this paper
• Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and

  2012cites this paper
• Diagnosis of Cardiovascular Disease in Patients with Chronic Kidney Disease

  2012cites this paper
• Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

  2012cites this paper
• Neurologic Aspects of Kidney Disease

  2012cites this paper
• Kidney Dysfunction, Cardiorespiratory Fitness, and the Risk of Death in Women

  2012influential citation
• Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).

  2012cites this paper
• Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

  2012cites this paper
• Pharmacologic Issues in treating hypertension in CKD.

  2011cites this paper
• Epidemiology and Prevention Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Statement From the American Heart Association Councils on Kidney in Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A

  2011cites this paper
• Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.

  2011cites this paper
• The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.

  2011cites this paper
• Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: A cohort study

  2011cites this paper
• Percutaneous coronary revascularization for myocardial infarction in chronic kidney disease: recognizing the risk while seizing the benefits.

  2011cites this paper
• Cardiovascular Disease in End Stage Renal Disease Patients

  2011cites this paper
• Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.

  2011cites this paper
• Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.

  2011cites this paper
• Management of patients with chronic kidney disease

  2011cites this paper
• Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease

  2011cites this paper
• The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.

  2011cites this paper
• The Relationship Between Chronic Kidney Disease and SYNTAX Score

  2011cites this paper
• Decreased Glomerular Filtration Rate is an Independent Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2011cites this paper
• Coronary Treatment and Intervention Outcomes Network Registry With Chronic Kidney Disease : A Report From the National Cardiovascular Data Acute ST-Segment Elevation Myocardial Infarction in Patients − Myocardial Infarction and Non Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment

  2010cites this paper
• Chronic kidney disease, all-cause mortality and cardiovascular mortality among Chinese patients with established cardiovascular disease.

  2010cites this paper
• Chronic kidney disease in hypertension under specialist care: the I-DEMAND study

  2010cites this paper
• Applying evidence into routine clinical care at a unit level: The exemplar of renal anaemia management

  2010influential citation
• New-onset atrial fibrillation and acute coronary syndrome

  2010cites this paper
• Relation between combining evidence-based medications on mortality following myocardial infarction in patients with and without renal impairment

  2010cites this paper
• Cardiorenal Interaction: Appropriate Treatment of Cardiovascular Risk Factors to Improve Outcomes in Chronic Kidney Disease

  2010cites this paper
• Coronary Heart Disease Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non – ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Interve

  2010cites this paper
• Coronary revascularisation in chronic kidney disease. Part II: acute coronary syndromes.

  2010cites this paper
• The cardiorenal syndrome in diabetes mellitus.

  2010cites this paper
• Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R

  2010cites this paper
• Diabetes Mellitus: Is the Presence of Nephropathy Important as a Cardiovascular Risk Factor for Cardioneral Syndrome?

  2010cites this paper
• Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project.

  2010cites this paper
• Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

  2010cites this paper
• Chronic Kidney Disease as a Predictor of Coronary Lesion Morphology

  2010cites this paper